|
General Information
|
|
|
Product
|
ergo-1 Peptide
|
|
Description
|
Antigenic Blocking Peptide Endogenous-RNAi deficient arGOnaute protein N-epitope
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 790-840 on C.elegans Endogenous-RNAi deficient arGOnaute proteinn.
|
|
Accession #
|
NCBI: NP_503362.2
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Determinant
|
N-epitope
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
O61931
|
|
Overview
|
Argonaute protein required for gene silencing in the endogenous RNA interference (RNAi) pathway. Interacts with 26G small interfering RNAs (26G-siRNAs) and required for subsequent biogenesis of secondary 22G-siRNAs. May be involved in passenger strand cleavage of target 26G-siRNAs (PubMed: 22102828).
|
|
Molecular Function
|
Dead/H-box RNA helicase binding, nucleic acid binding, production of siRNA involved in RNA interference, regulation of translation, RNA interference.
|
|
Subcellular Location
|
Cytoplasm
|
|
Structure
|
Belongs to the argonaute family. Piwi subfamily. Contains 1 PAZ domain. Contains 1 Piwi domain. |
| Expression |
Expressed in embryos and during larval development up to larval stage 2. |
|
Alternative Nomenclature
|
Endogenous RNAi deficient argonaute antibody
Ergo 1 antibody
Hypothetical protein R09A1.1 antibody
|
| |
|
ergo-1 Antibody
ergo-1 Antibody FITC
ergo-1 Antibody BIOTIN
ergo-1 Positive Control
